No abstract available
MeSH terms
-
Antibodies, Bispecific / adverse effects*
-
Antineoplastic Agents, Immunological / adverse effects*
-
Female
-
Histone-Lysine N-Methyltransferase / genetics
-
Humans
-
Leukemia, Monocytic, Acute / etiology*
-
Leukemia, Monocytic, Acute / genetics
-
Molecular Targeted Therapy / adverse effects*
-
Myeloid-Lymphoid Leukemia Protein / genetics
-
Neoplasms, Second Primary / genetics*
-
Neoplasms, Second Primary / pathology
-
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
-
Young Adult
Substances
-
Antibodies, Bispecific
-
Antineoplastic Agents, Immunological
-
KMT2A protein, human
-
Myeloid-Lymphoid Leukemia Protein
-
blinatumomab
-
Histone-Lysine N-Methyltransferase